Full-Time

Sales Director

Confirmed live in the last 24 hours

Certara

Certara

1,001-5,000 employees

Biosimulation and data science solutions provider

No salary listed

Expert

Melbourne VIC, Australia

Category
Strategic Account Management
Sales & Account Management
Required Skills
Lead Generation
Word/Pages/Docs
Salesforce
Excel/Numbers/Sheets
Requirements
  • 10+ years as a business development manager, preferably within the top 50 pharmaceutical companies and enterprise B2B SaaS industry
  • Master’s degree (in a science discipline) or advanced business degree preferred
  • Excellent communication skills, both verbal and written
  • Attention to detail for capturing all sales interaction into Salesforce
  • Strong organizational skills with the ability to multi-task and set priorities
  • Ability to work in a high energy team environment
  • Able to fully utilize the MS Office suite (Excel/Word/PPT)
  • Proven track record of high level of sales performance in a competitive, dynamic market place
  • Speaks fluent English
Responsibilities
  • Establish multiple-level contacts within assigned accounts by presenting to, consulting with, and cultivating relationships at all influencers levels including the C-level executives.
  • Qualify companies and contacts to understand the customer’s key needs/challenges through identification, discovery, planning and account/customer qualifications.
  • Grow sales by successfully initiating client contacts, generate new leads, and follow up on assigned leads.
  • Identify, profile and aggressively pursue new clients in the life sciences industry.
  • Grow sales and follow-up leads into sales through professional key account management.
  • Develop client specific solutions presentations and contribute to the RFP response and proposal process, developing appropriate win strategies based on your knowledge of the client.
  • Work with marketing to formulate lead-generation plans that will lead to new revenue generation opportunities.
  • Participate in professional trade shows and clinical conferences, or the equivalent, (or as practically possible), setting up client meetings, exhibit coverage and lead generation.
  • Document communication/discussions and all opportunity details in SalesForce.com to ensure a tracked record of existing correspondence and/or future next steps required.
  • Utilize market knowledge and industry contacts to grow the Software business in line with agreed commercial goals. This will include pursuing new product opportunities, identifying new contacts and accounts, and broadening the range of business in existing accounts.
  • Meet/exceed sales quota on a monthly, quarterly, and annual basis.
  • Follow Certara processes and best practices for properly working Marketing Qualified Leads (MQLs)
  • Document all activities (phone and email outreach) within our Salesforce Lightning CRM
Desired Qualifications
  • High degree of professionalism: Lives the values of transparency, authenticity, collaboration, respect and accountability
  • Has a “Growth Mindset”
  • Is a “Continuous Learner”

Certara provides biosimulation and data science solutions to enhance drug development and regulatory submissions. Their products include software and consulting services that help pharmaceutical and biotechnology companies, as well as regulatory agencies, make better decisions throughout the drug development process. Certara's software allows users to simulate biological processes and visualize data, which aids in improving the efficiency and success rates of clinical trials. Unlike many competitors, Certara combines advanced technologies like deep learning and artificial intelligence in their offerings. The company's goal is to optimize the drug development lifecycle, making it more effective and successful.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Princeton, New Jersey

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • Certara's acquisition of Chemaxon enhances its drug discovery software portfolio.
  • The biosimulation market is projected to grow significantly, benefiting Certara.
  • Certara's CoAuthor platform streamlines medical writing, improving efficiency.

What critics are saying

  • Increased competition could erode Certara's market share.
  • Rapid technological advancements may outpace Certara's current capabilities.
  • Regulatory scrutiny on AI tools could delay Certara's product approvals.

What makes Certara unique

  • Certara offers a unique combination of biosimulation and data science solutions.
  • The company leverages AI to enhance drug development and regulatory submissions.
  • Certara's Phoenix software is a gold standard in pharmacokinetic modeling.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-3%

2 year growth

-3%
Stock Titan
Mar 5th, 2025
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

Certara (NASDAQ: CERT) has appointed Dr. Adrian McKemey as President of Drug Development Solutions, effective March 3rd, 2025.

Hit Consultant
Jan 17th, 2025
Recent Digital Health Executive Hires And Promotions: Medidata Expands Team, Carerev, Philips, Eko Health, Others

AVIZVA, a health-tech organization that offers a variety of solutions for healthcare enterprises, that it has appoints James Vertino as its new CEO.Model N appoints Bret Connor as Chief Executive Officer. The Board of Directors of Blue Shield of California appoints Lois Quam as chief executive officer to lead Blue Shield of California, the first woman to serve as CEO in the health plan’s 86-year history. She joined the company as president in 2024.   Yaqrit, a late-stage biotech and medtech company developing lifesaving treatments for advanced liver diseases appoints Troels Jordansen has joined Yaqrit as Chief Executive Officer.OP Solutions names Michael Kallish as Chief Executive Officer, effective immediately.Access TeleCare appoints Dr. Michael Genovese to Chief Medical Officer for Behavioral Health.Enveda appoints Jason Kim as Chief Financial Officer (CFO).Eko Health appoints of Justin Spencer as Chief Financial Officer (CFO). (Pull from site)Qure.ai appoints Jim Mercadante as its new Chief Commercial Officer. (Pull from site)Symplr, appoints Dr

PharmiWeb
Oct 18th, 2024
Biosimulation Market to Grow at a CAGR of 21.5% During the Ensuing Ten years, Reaching USD 20.9 Billion by the end of 2032.

In June 2022, Certara announced its new version of Biosimulation software for the progress of Novel Biologics.

Certara
Oct 16th, 2024
Certara Appoints John Reynders as New Independent Board Member

Certara appoints John Reynders as new independent board member.

GlobeNewswire
Aug 15th, 2024
Certara Launches Phoenix(Tm) Version 8.5 Drug Development Software

RADNOR, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Phoenix™ version 8.5. Phoenix is the pharmaceutical industry's gold standard in pharmacokinetic/pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software. The Phoenix Platform is used by more than 75 of the top 100 pharmaceutical companies worldwide. Eleven regulatory agencies, including the U.S